Anthem Blue Cross and Blue Shield Nevada prior authorization, page 58

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
0560UOncology (minimal residual disease [MRD]), genomic sequence analysis, cell- free DNA, whole blood and tumor tissue, baseline assessment for design and construction of a personaNevada Prior Authorization List, Pg 127 Original policy
0561UOncology (minimal residual disease [MRD]), genomic sequence analysis, cell- free DNA, whole blood, subsequent assessment with comparison to initial assessment to evaluate for MNevada Prior Authorization List, Pg 127 Original policy
0562UOncology (solid tumor), targeted genomic sequence analysis, 33 genes, detection of single-nucleotide variants (SNVs), insertions and deletions, copy- number amplifications, andNevada Prior Authorization List, Pg 127 Original policy
0563TEvacuation of meibomian glands, using heat delivered through wearable, open- eye eyelid treatment devices and manual gland expression, bilateralNevada Prior Authorization List, Pg 128 Original policy
0565TAutologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; tissue harvesting and cellular implant creationNevada Prior Authorization List, Pg 128 Original policy
0565UOncology (hepatocellular carcinoma), next-generation sequencing methylation pattern assay to detect 6626 epigenetic alterations, cell-free DNA, plasma, algorithm reported as cNevada Prior Authorization List, Pg 128 Original policy
0566TAutologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; injection of cellular implant into knee joint including ultrasound guNevada Prior Authorization List, Pg 128 Original policy
0566UOncology (lung), qPCR-based analysis of 13 differentially methylated regions (CCDC181, HOXA7, LRRC8A, MARCHF11, MIR129-2, NCOR2, PANTR1, PRKCB, SLC9A3, TBR1_2, TRAP1, VWC2, ZNNevada Prior Authorization List, Pg 128 Original policy
0567URare diseases (constitutional/heritable disorders), whole-genome sequence analysis combination of short and long reads, for single-nucleotide variants, insertions/deletions anNevada Prior Authorization List, Pg 128 Original policy
0568UNeurology (dementia), beta amyloid (AB40, AB42, AB42/40 ratio), tau-protein phosphorylated at residue (eg, pTau217), neurofilament light chain (NfL), and glial fibrillary acidNevada Prior Authorization List, Pg 128 Original policy
0569TTranscatheter tricuspid valve repair, percutaneous approach; initial prosthesisNevada Prior Authorization List, Pg 128 Original policy
0569UOncology (solid tumor), next-generation sequencing analysis of tumor methylation markers (>20000 differentially methylated regions) present in cell- free circulating tumor DNANevada Prior Authorization List, Pg 128 Original policy
0571UOncology (solid tumor), DNA (80 genes) and RNA (10 genes), by next-generation sequencing, plasma, including single-nucleotide variants, insertions/deletions, copy-number alterNevada Prior Authorization List, Pg 128 Original policy
0580TRemoval of substernal implantable defibrillator pulse generator onlyNevada Prior Authorization List, Pg 128 Original policy
0581TAblation, malignant breast tumor(s), percutaneous, cryotherapy, including imaging guidance when performed, unilateralNevada Prior Authorization List, Pg 128 Original policy
0584TIslet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when perfNevada Prior Authorization List, Pg 128 Original policy
0585TIslet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when perfNevada Prior Authorization List, Pg 128 Original policy
0586TIslet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when perfNevada Prior Authorization List, Pg 128 Original policy
0587TPercutaneous implantation or replacement of integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generatorNevada Prior Authorization List, Pg 128 Original policy
0588TRevision or removal of percutaneously placed integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generatorNevada Prior Authorization List, Pg 128 Original policy
0589UPerfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), 24 PFAS compounds by high-performance liquid chromatography with tandem mass specNevada Prior Authorization List, Pg 128 Original policy
0596TTemporary female intraurethral valve-pump (ie, voiding prosthesis); initial insertion, including urethral measurementNevada Prior Authorization List, Pg 128 Original policy
0597TTemporary female intraurethral valve-pump (ie, voiding prosthesis); replacementNevada Prior Authorization List, Pg 128 Original policy
0600TAblation, irreversible electroporation; 1 or more tumors per organ, other than liver or prostate, including imaging guidance, when performed, percutaneousNevada Prior Authorization List, Pg 128 Original policy
0601TAblation, irreversible electroporation; 1 or more tumors per organ, including fluoroscopic and ultrasound guidance, when performed, openNevada Prior Authorization List, Pg 128 Original policy
0607TRemote monitoring of an external continuous pulmonary fluid monitoring system, including measurement of radiofrequency-derived pulmonary fluid levels, heart rate, respirationNevada Prior Authorization List, Pg 129 Original policy
0608TRemote monitoring of an external continuous pulmonary fluid monitoring system, including measurement of radiofrequency-derived pulmonary fluid levels, heart rate, respirationNevada Prior Authorization List, Pg 129 Original policy
0615TAutomated analysis of binocular eye movements without spatial calibration, including disconjugacy, saccades, and pupillary dynamics for the assessment of concussion, with inteNevada Prior Authorization List, Pg 129 Original policy
0620TEndovascular venous arterialization, tibial or peroneal vein, with transcatheter placement of intravascular stent graft(s) and closure by any method, including percutaneous orNevada Prior Authorization List, Pg 129 Original policy
0627TPercutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, unilateral or bilateral injection, with fluoroscopic guidance, lumbar; first leNevada Prior Authorization List, Pg 129 Original policy
0629TPercutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, unilateral or bilateral injection, with CT guidance, lumbar; first levelNevada Prior Authorization List, Pg 129 Original policy
0633TComputed tomography, breast, including 3D rendering, when performed, unilateral; without contrast materialNevada Prior Authorization List, Pg 129 Original policy
0634TComputed tomography, breast, including 3D rendering, when performed, unilateral; with contrast material(s)Nevada Prior Authorization List, Pg 129 Original policy
0635TComputed tomography, breast, including 3D rendering, when performed, unilateral; without contrast, followed by contrast material(s)Nevada Prior Authorization List, Pg 129 Original policy
0636TComputed tomography, breast, including 3D rendering, when performed, bilateral; without contrast material(s)Nevada Prior Authorization List, Pg 129 Original policy
0637TComputed tomography, breast, including 3D rendering, when performed, bilateral; with contrast material(s)Nevada Prior Authorization List, Pg 129 Original policy
0638TComputed tomography, breast, including 3D rendering, when performed, bilateral; without contrast, followed by contrast material(s)Nevada Prior Authorization List, Pg 129 Original policy
0646TTranscatheter tricuspid valve implantation/replacement (TTVI) with proNevada Prior Authorization List, Pg 129 Original policy
0648TQuantitative magnetic resonance for analysis of tissue composition (eg, fat, iron, water content), including multiparametric data acquisition, data preparation and transmissioNevada Prior Authorization List, Pg 129 Original policy
0652TEsophagogastroduodenoscopy, flexible, transnasal; diagnostic, includinNevada Prior Authorization List, Pg 129 Original policy
0653TEsophagogastroduodenoscopy, flexible, transnasal; with biopsy, singleNevada Prior Authorization List, Pg 129 Original policy
0654TEsophagogastroduodenoscopy, flexible, transnasal; with insertion of inNevada Prior Authorization List, Pg 129 Original policy
0655TTransperineal focal laser ablation of malignant prostate tissue, incluNevada Prior Authorization List, Pg 129 Original policy
0658TElectrical impedance spectroscopy of 1 or more skin lesions for automaNevada Prior Authorization List, Pg 129 Original policy
0659TTranscatheter intracoronary infusion of supersaturated oxygen in conjuNevada Prior Authorization List, Pg 129 Original policy
0664TDonor hysterectomy (including cold preservation); open, from cadaver dNevada Prior Authorization List, Pg 129 Original policy
0665TDonor hysterectomy (including cold preservation); open, from living doNevada Prior Authorization List, Pg 129 Original policy
0666TDonor hysterectomy (including cold preservation); laparoscopic or roboNevada Prior Authorization List, Pg 129 Original policy
0667TDonor hysterectomy (including cold preservation); recipient uterus allNevada Prior Authorization List, Pg 130 Original policy
0668TBackbench standard preparation of cadaver or living donor uterine alloNevada Prior Authorization List, Pg 130 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.